Based in Belgium, Axithra is a startup. Brouky records 1 investor associated with the company.
Axithra is developing a photonics-based point-of-care device that uses Raman spectroscopy on a chip to rapidly detect and quantify the active (free) fraction of drugs in patient blood for therapeutic drug monitoring. The technology is under development and clinical investigation and is not yet FDA cleared or CE-marked.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.